The final episode of the seven-part series explores what action the University of Leeds is taking to beat cancer.
The funding provided through BBSRC’s Pioneer Awards allows investigators to explore untested bioscience ideas that challenge conventional thinking and open up novel areas of exploration.
A biotech company and University of Leeds researchers aim to develop new technology that can treat “death signals” found in corneal disease and eye injuries.
For the first time, scientists have witnessed new molecular behaviour in proteins that protect us from cancer.
Scientists discover promising new way to personalise treatment for patients with cancer and autoimmune diseases
Researchers at the University of Leeds have developed a new diagnostic approach that can quickly identify how a patient is responding to antibody medication.